PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

Government confirms increase to pharma’s statutory scheme 9 Mar 2023

Despite opposition from the Association of the British Pharmaceutical Industry (ABPI), the UK government has confirmed its plans to raise the revenue clawback rate paid by pharma for branded medicines under the statutory scheme by just over 3%, from 24.4% to 27.5% for 2023. 

 The statutory scheme sits alongside the 2019 voluntary scheme for branded medicines pricing and access (VPAS), to control the prices of branded medicines to the NHS. Pharma companies pay either under the statutory scheme or opt for the voluntary one. 

 Following consultation with interested parties between December 2022 and January 2023, the government states that it expects the change to result in savings of £17-19 million by 2023. It is in discussions with industry separately on a future voluntary scheme. 

 Read the government’s full consultation response here.

GeneralCategories

  • No categories

GeneralTags

#ABPI #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EMA #EU #FDA #innovation #JPMorgan #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicaldeviceregulation #medicaldevicesregulation #medtech #mentalhealth #mhra #NHS #NICE #outsourcing #pharmaregulation #pharmatrends #pre-eclampsia #R&D #raredisease #rarediseases #regulation #regulatory #UKgovernment #ukpharma #ukregulation #VPAS @PPharmamedic AI Biotech COVID-19 Healthcare Medical Affairs medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital